The company can attribute its financial success to product line sales, including the sale of reconstructive products, MedSurg products and neurotechnology and spine products. There was a higher recorded shipment of hip, trauma and extremities implant systems, which offset lower shipments of knee and other implant systems. However, the company also experienced a 3.1 percent net earnings decrease from $319 million in the second quarter of 2010 to $309 million during the second quarter of 2011.
The company’s hip business reported $312 million, an 11 percent increase over last year. The knee business only experienced a 4 percent increase to $328.5 million during the second quarter of this year. The company’s spine business experienced an 8 percent increase to $169 million.
During the second quarter, Stryker also acquired Orthovita.
Read the release on the financial report from Stryker.
Related Articles on Stryker:
Stryker Partners With RegenLab for Distributing PRP Kit
Stryker Releases ADM X3 Mobile Bearing Hip System
Staying Competitive in the Orthopedic Device Market: Q&A With Stryker Orthopaedics
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
